Can a New Drug Combo Prevent Death by Suicide?
A new study suggests that a combination of ketamine and buprenorphine may significantly reduce suicidal thoughts in patients. Researchers found that nearly 80 percent of participants receiving the drug combination were no longer clinically suicidal after a month. This promising result indicates the need for larger trials to further explore the treatment's potential.
- ▪Suicide rates remain a public health crisis despite a slight decline in recent years.
- ▪A study from Stanford University tested a combination of ketamine and buprenorphine on patients with major depressive disorder and suicidal ideation.
- ▪Results showed that nearly 80 percent of patients receiving buprenorphine were no longer clinically suicidal after one month.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"Article","headline":"Can a New Drug Combo Prevent Death by Suicide?","description":"Can a New Drug Combo Prevent Death by Suicide?: It may reduce suicidal intent for up to a month or more","image":["https://lede-admin.nautil.us/wp-content/uploads/sites/70/2026/05/French_hero_5497ac.png"],"datePublished":"2026-05-27T18:00:06+00:00","dateModified":"2026-05-27T18:00:08+00:00","author":[{"@type":"Person","name":"Kristen…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Nautil.
Discussion
0 commentsMore from Nautil
